Suppr超能文献

评估造影剂注射后优化磁共振灌注成像扫描时间窗对鉴别乳腺良恶性病变的作用。

Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions.

作者信息

Dong Jie, Wang Dawei, Ma Zhenshen, Deng Guodong, Wang Lanhua, Zhang Jiandong

机构信息

Department of Radiology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China.

Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China.

出版信息

Exp Ther Med. 2017 Mar;13(3):1069-1073. doi: 10.3892/etm.2017.4060. Epub 2017 Jan 18.

Abstract

The aim of the study was evaluate the 3.0 T magnetic resonance (MR) perfusion imaging scanning time window following contrast injection for differentiating benign and malignant breast lesions and to determine the optimum scanning time window for increased scanner usage efficiency and reduced diagnostic adverse risk factors. A total of 52 women with breast abnormalities were selected for conventional MR imaging and T1 dynamic-enhanced imaging. Quantitative parameters [volume transfer constant (K), rate constant (K) and extravascular extracellular volume fraction (V)] were calculated at phases 10, 20, 30, 40 and 50, which represented time windows at 5, 10, 15, 20 and 25 min, respectively, following injection of contrast agent. The association of the parameters at different phases with benign and malignant tumor diagnosis was analyzed. MR perfusion imaging was verified as an effective modality in the diagnosis of breast malignancies and the best scanning time window was identified: i) Values of K and K at all phases were statistically significant in differentiating benign and malignant tumors (P<0.05), while the value of V had statistical significance only at stage 10, but not at any other stages (P>0.05); ii) values of V in benign tumors increased with phase number, but achieved no obvious changes at different phases in malignant tumors; iii) the optimum scanning time window of breast perfusion imaging with 3.0 T MR was between phases 10 and 30 (i.e., between 5 and 15 min after contrast agent injection). The variation trend of V values at different phases may serve as a diagnostic reference for differentiating benign and malignant breast abnormalities. The most efficient scanning time window was indicated to be 5 min after contrast injection, based on the observation that the V value only had statistical significance in diagnosis at stage 10. However, the optimal scanning time window is from 5 to 15 min following the injection of contrast agent, since that the variation trend of V is able to serve as a diagnostic reference.

摘要

本研究的目的是评估注射造影剂后 3.0 T 磁共振(MR)灌注成像的扫描时间窗,以鉴别乳腺良恶性病变,并确定最佳扫描时间窗,以提高扫描仪使用效率并降低诊断不良风险因素。共选取 52 例有乳腺异常的女性进行常规 MR 成像和 T1 动态增强成像。在第 10、20、30、40 和 50 期计算定量参数[容积转运常数(K)、速率常数(K)和血管外细胞外容积分数(V)],这些分别代表注射造影剂后 5、10、15、20 和 25 分钟的时间窗。分析不同期参数与良恶性肿瘤诊断的相关性。MR 灌注成像被证实是诊断乳腺恶性肿瘤的有效方法,并确定了最佳扫描时间窗:i)各期 K 和 K 值在鉴别良恶性肿瘤方面具有统计学意义(P<0.05),而 V 值仅在第 10 期具有统计学意义,在其他任何期均无统计学意义(P>0.05);ii)良性肿瘤中 V 值随期数增加,而恶性肿瘤在不同期无明显变化;iii)3.0 T MR 乳腺灌注成像的最佳扫描时间窗在第 10 期和第 30 期之间(即注射造影剂后 5 至 15 分钟)。不同期 V 值的变化趋势可作为鉴别乳腺良恶性异常的诊断参考。基于 V 值仅在第 10 期诊断中有统计学意义的观察结果,最有效的扫描时间窗显示为注射造影剂后 5 分钟。然而,最佳扫描时间窗是注射造影剂后 5 至 15 分钟,因为 V 的变化趋势能够作为诊断参考。

相似文献

2
Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.
Exp Ther Med. 2015 Mar;9(3):913-918. doi: 10.3892/etm.2014.2154. Epub 2014 Dec 22.
3
[Signal intensity-time curve and quantitative dynamic contrast-enhanced magnetic resonance imaging in differentiating neoplasms of uterus].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Dec;40(12):1357-64. doi: 10.11817/j.issn.1672-7347.2015.12.012.
6
Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
Curr Med Imaging. 2022;18(10):1099-1105. doi: 10.2174/1573405618666220324112457.
7
Quantitative perfusion parameters of benign inflammatory breast pathologies: A descriptive study.
Clin Imaging. 2020 Dec;68:249-256. doi: 10.1016/j.clinimag.2020.08.024. Epub 2020 Aug 27.

本文引用的文献

1
Multiparametric MR Imaging of Breast Cancer.
Magn Reson Imaging Clin N Am. 2016 Feb;24(1):223-238. doi: 10.1016/j.mric.2015.08.012.
3
Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.
Exp Ther Med. 2015 Mar;9(3):913-918. doi: 10.3892/etm.2014.2154. Epub 2014 Dec 22.
5
Molecular imaging for the characterization of breast tumors.
Expert Rev Anticancer Ther. 2014 Jun;14(6):711-22. doi: 10.1586/14737140.2014.885383. Epub 2014 Feb 19.
8
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Magn Reson Med. 2014 Apr;71(4):1592-602. doi: 10.1002/mrm.24782. Epub 2013 May 9.
9
Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
J Magn Reson Imaging. 2012 Jul;36(1):145-51. doi: 10.1002/jmri.23635. Epub 2012 Mar 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验